TORRENT PHARMACEUTICALS
Back to Cashflow Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹10,151 Cr | ₹-2,298 Cr | ₹-2,780 Cr | ₹77 Cr | ₹-1,781 Cr |
What is the latest Cash Flow from Financing Activities ratio of TORRENT PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹10,151 Cr |
| Mar2025 | ₹-2,298 Cr |
| Mar2024 | ₹-2,780 Cr |
| Mar2023 | ₹77 Cr |
| Mar2022 | ₹-1,781 Cr |
How is Cash Flow from Financing Activities of TORRENT PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹10,151 Cr | Positive | |
| Mar2025 | ₹-2,298 Cr | Negative | |
| Mar2024 | ₹-2,780 Cr | Negative | |
| Mar2023 | ₹77 Cr | Positive | |
| Mar2022 | ₹-1,781 Cr | - | |
Compare Cash Flow from Financing Activities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹181,641.0 Cr | 1% | 2.5% | 33.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 7.3% | 8.4% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 15.3% | 24.1% | 63% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | 1% | 15.9% | 14% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 0.4% | 7.9% | -6.2% | Stock Analytics | |
| MANKIND PHARMA | ₹109,911.0 Cr | 5.1% | 12.3% | 8.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 1% |
2.5% |
33.4% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses